“Tourism Doing Business Investing in Namibia” aims to attract potential investors and provides essential insights into the vibrant opportunities within Namibia’s tourism sector. The guidelines showcase Namibia’s unique cultural heritage, robust economy, and supportive business environment, highlighting areas of potential significant growth in the years ahead. Namibia: A thriving tourism ecosystem Namibia, known for its breathtaking landscapes and rich cultural heritage, is poised for signific...

Invivoscribe, a global leader in precision diagnostics, is pleased to announce the successful listings of the LeukoStrat CDx FLT3 Mutation Assay in both the United Kingdom (UK) and Switzerland. The LeukoStrat CDx FLT3 Mutation Assay aids in the accurate detection of FLT3 mutations, empowering clinicians to make informed treatment decisions. This milestone ensures expanded accessibility of critical treatments to patients diagnosed with acute myeloid leukemia (AML). Regulatory compliance in the ...

Everen Limited today announced a dividend of $350 million, affirming Everen’s commitment to delivering value to its shareholders. The decision by Everen’s Board of Directors was announced at the Company’s Annual General Meeting (AGM) in Bermuda on Thursday, March 20, 2025. The dividend is payable on or before September 30, 2025 to shareholders of record on March 20, 2025. Robert Foskey, President & CEO of the Everen Group, commented: “Everen continues to go from strength to strength with ...